We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The financial hazard of personalized medicine and supportive care.
- Authors
Carrera, Pricivel; Olver, Ian; Carrera, Pricivel M
- Abstract
Personalized medicine is revolutionizing the delivery of oncological care, promising benefits both at the patient and health system levels. The cost of targeted therapies, unfortunately, is becoming more expensive and unaffordable. Where supportive care in cancer concerns the prevention and management of the adverse effects of cancer and its treatment and is the thrust of the Multinational Association of Supportive Care in Cancer, financing of and value in personalized medicine is an important area of research and engagement for the association. Discussing patients' concerns with and identifying those at most risk for the financial hazard of cancer treatment and offering financial counseling and assistance and/or referral to support networks are potential key areas for (exploring and providing) better supportive care. The time is now to turn the concern of patients and their carers, providers, and other advocates regarding the affordability of cancer treatment into a collective cause towards coordinated action.
- Subjects
INDIVIDUALIZED medicine; DRUG delivery systems; CANCER patients; CANCER prevention; CANCER treatment; MEDICAL care costs; COUNSELING; ECONOMIC statistics; LUNG cancer treatment; TUMOR treatment; TREATMENT of lung tumors; PALLIATIVE treatment; LUNG tumors; TUMORS; LUNG cancer; ECONOMIC aspects of diseases; MEDICAL referrals; UNCERTAINTY; DISEASE management; ECONOMICS
- Publication
Supportive Care in Cancer, 2015, Vol 23, Issue 12, p3399
- ISSN
0941-4355
- Publication type
journal article
- DOI
10.1007/s00520-015-2922-3